* Eikon search string for individual stock moves:
* The Day Ahead newsletter: tmsnrt.rs/2ggOmBi
* The Morning News Call newsletter: tmsnrt.rs/2fwPLTh U.S. stocks were set to open lower on Monday, as weak data from China brought back fears of a slowdown in the world's second-biggest economy, while investors looked for any positive news on trade talks ahead of a tariff deadline later in the week.
At 9:07 ET, Dow e-minis were down 0.10% at 27,985. S&P 500 e-minis were down 0.12% at 3,142.25, while Nasdaq 100 e-minis were down 0.17% at 8,386. The top three NYSE percentage gainers premarket: ** PG&E Corp, up 17.4% ** Quanta Services Inc, up 14.6% ** Roadrunner Transportation Systems Inc, up 10.9% The top three NYSE percentage losers premarket: ** Diplomat Pharmacy Inc, down 31.8% ** PT Telekomunikasi Indonesia Tbk, down 13.5% ** Brigham Minerals Inc, down 4.4% The top three Nasdaq percentage gainers premarket: ** Synthorx Inc, up 169.2% ** XBiotech Inc, up 112.7% ** ArQule Inc, up 102.6% The top three Nasdaq percentage losers premarket: ** Biocept Inc, down 27.8% ** Lincoln Educational Services Corp, down 17.3% ** KalVista Pharmaceuticals Inc, down 17% ** Qorvo Inc: up 2.7% premarket ** Skyworks Solutions Inc: up 2.2% premarket BUZZ-Qorvo, Skyworks gain on report of BAML double-upgrade ** Canopy Growth Corp: up 4.2% premarket BUZZ-Rises on appointment of new CEO ** ArQule: up 102.6% premarket ** Merck & Co: up 0.4% premarket BUZZ-Surges after Merck offers 107% premium to buy co ** 3M: down 1.2% premarket BUZZ-Falls as Citigroup cuts to “neutral” citing litigation risk ** Diplomat Pharmacy: down 31.8% premarket BUZZ-Drops on discounted buyout by UnitedHealth unit ** Synthorx Inc: up 169.2% premarket ** Sanofi: down 0.5% premarket BUZZ-Synthorx set for record high on Sanofi’s $2.5 bln buyout offer ** PG&E Corp: up 17.4% premarket BUZZ-Up on $13.5 bln settlement with wildfire victims ** Macy’s: down 1.8% premarket BUZZ-Slips as Goldman Sachs says sell - thefly.com ** Achieve Life Sciences Inc: up 24.1% premarket BUZZ-Up on FDA nod for late-stage study of anti-smoking drug ** Onconova Therapeutics Inc: down 13.1% premarket BUZZ-Falls on stock-and-warrants offering (Compiled by Shanti S Nair in Bengaluru)
Our Standards: The Thomson Reuters Trust Principles.